Skip to main content
JAMA Network logoLink to JAMA Network
. 2023 Jul 20;9(7):1009. doi: 10.1001/jamaoncol.2023.2581

Errors in Figure 3

PMCID: PMC10359959  PMID: 37470838

The Original Investigation titled “Association of MGMT Promotor Methylation With Survival in Low-grade and Anaplastic Gliomas After Alkylating Chemotherapy,”1 published online May 18, 2023, included errors on the x-axis of each panel in Figure 3; the unit of measure should be time in years, not months. eFigures 1, 2, 5, and 8 in Supplement 1 were also updated. This article has been corrected online.

Reference

  • 1.Kinslow CJ, Mercurio A, Kumar P, et al. Association of MGMT promotor methylation with survival in low-grade and anaplastic gliomas after alkylating chemotherapy. JAMA Oncol. Published online May 18, 2023. doi: 10.1001/jamaoncol.2023.0990 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from JAMA Oncology are provided here courtesy of American Medical Association

RESOURCES